Chinese Traditional and Herbal Drugs
|
2025, 56(20): 7461-7471
Precision therapeutic strategies and mechanism prediction of traditional Chinese medicine compound prescriptions for amyotrophic lateral sclerosis based on patent data mining and transcriptomics
Full
GUAN Shuang1, WANG Sicun1, SHI Yinli1, LENG Yuanyuan1, YU Yanan1, WANG Zhong1, LIU Jun1
Affiliations
1 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
doi: 10.7501/j.issn.0253-2670.2025.20.017
Outline
Objective To explore the compatibility patterns and precision treatment strategies of traditional Chinese medicine (TCM) prescriptions for amyotrophic lateral sclerosis (ALS) using patent data mining and transcriptomic analysis. Methods TCM prescriptions patents for ALS were screened from the Chinese Patent Database. Frequency statistics and association analysis were applied to identify core herbs and compatibility patterns. The traditional Chinese medicine systems pharmacology (TCMSP) and a high-throughput experiment- and reference-guided database of TCM (HERB) databases were utilized to construct prescriptions-target networks, and module partitioning was employed to identify core target modules. ALS patients were classified into transcriptional subgroups via non-negative matrix factorization (NMF) based on the GSE16989 transcriptomic dataset. Vertex/Edge Overlap (VEO) algorithm was used to screen subgroups-specific optimal prescriptions, while restart random walk (RWR) and the SymMap platform were applied to predict syndrome characteristics. Results Analysis of 11 ALS TCM prescriptions patents (containing 101 herbs) revealed Astragali Radix, Poria, Ginseng Radix et Rhizoma, Epimedii Folium, and Angelicae Sinensis Radix as high-frequency core herbs. Association rule mining identified key herb pairs, with Atractylodis Macrocephalae Rhizoma-Epimedii Folium and Atractylodis Macrocephalae Rhizoma-Poria showing the strongest compatibility correlations. NMF analysis classified ALS patients into four molecular subgroups: group 1 was significantly enriched in the interleukin-17 (IL-17) signaling pathway, group 2 showed no significant pathway enrichment; group 3 and group4 were co-enriched in the viral protein-cytokine receptor interaction pathway. Subgroups-specific optimal prescriptions were identified via VEO similarity: prescriptions 11 for group1, prescriptions 9 for group 2, and prescriptions 8 for group 3 and group 4. Syndrome stratification was performed using RWR and SymMap. Conclusion This study elucidates the precision treatment potential of TCM prescriptions for ALS by integrating transcriptomic subgroups with TCM syndrome characteristics, providing a scientific foundation for “disease-syndrome combination” therapy in ALS.
amyotrophic lateral sclerosis
/
traditional Chinese medicine prescriptions
/
patent mining
/
transcriptomics
/
precision treatment
关双, 王思村, 石崯力, 冷媛媛, 于亚南, 王忠, 刘骏.
基于专利数据挖掘与转录组学的肌萎缩侧索硬化症中药复方精准治疗策略及机制预测.
中草药,
2025
, 56
(20)
: 7461
-7471
.
DOI: 10.7501/j.issn.0253-2670.2025.20.017
GUAN Shuang, WANG Sicun, SHI Yinli, LENG Yuanyuan, YU Yanan, WANG Zhong, LIU Jun.
Precision therapeutic strategies and mechanism prediction of traditional Chinese medicine compound prescriptions for amyotrophic lateral sclerosis based on patent data mining and transcriptomics[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(20)
: 7461
-7471
.
DOI: 10.7501/j.issn.0253-2670.2025.20.017
Year 2025 volume 56 Issue 20
63
14
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.20.017
- Receive Date:2025-07-08
- Online Date:2026-11-13